Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer-Reference-Cited by-同舟云学术

Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer

Published:2019-06-19 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Ma Peiwen,Beatty Pamela L.,McKolanis John,Brand Randal,Schoen Robert E.,Finn Olivera J.

Funder

Division of Cancer Prevention, National Cancer Institute

China Scholarship Council

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference31 articles.

1. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model;Meyer;Proc Natl Acad Sci USA,2011

2. Myeloid suppressor cells in cancer and autoimmunity;Sica;J Autoimmun,2017

3. The nature of myeloid-derived suppressor cells in the tumor microenvironment;Kumar;Trends Immunol,2016

4. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards;Bronte;Nat Commun,2016

5. Myeloid-derived suppressor cells in malignant melanoma;Umansky;J Dtsch Dermatol Ges,2014

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Tubeimoside I liposomal drug delivery system in combination with gemcitabine for the treatment of pancreatic cancer;Nanomedicine;2024-09-03

2. 5-Fluorouracil resistance due to sphingosine kinase 2 overexpression in colorectal cancer is associated with myeloid-derived suppressor cell-mediated immunosuppressive effects;BMC Cancer;2024-08-08

3. Revealing the effect of X-ray or proton brain irradiation on systemic inflammation and leukocyte subpopulation interplay in rodents;Journal of Leukocyte Biology;2024-07-02

4. Impact of obesity‑associated myeloid‑derived suppressor cells on cancer risk and progression (Review);International Journal of Oncology;2024-06-27

5. Outcome of Cyclophosphamide Treatment Following Hematopoietic Stem Cell Transplantation in a Thalassemia Patient: A Case Study;IRAN J IMMUNOL;2024